{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T17:03:39Z","timestamp":1777914219872,"version":"3.51.4"},"reference-count":44,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Psychological Medicine"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>South Asia generally reports low levels of amphetamine-type stimulant (ATS) use, with few studies on the pattern of ATS use. We assessed the pattern of ATS use and associated high-risk behavior in Manipur, a north-eastern state of India.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>209 adult male ATS users (mean age 28.8 years) from three districts of Manipur were interviewed. Data were collected on the patterns of high-risk behavior with ATS use, health consequences, and help-seeking. The severity of use with various substances was assessed using the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST). Depression and anxiety were assessed by the Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder (GAD-7) scale, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The mean duration of ATS use was 3.7 years (SD 2.3). The majority used ATS almost daily (88%) and depended on ATS (77%). Methamphetamine (99.5%) was the most used ATS orally. Around 87% also suffered from opioid dependence. About 76% injected drugs, most commonly heroin. Almost three-fourths (78%) used ATS before their sexual intercourse, 31% of whom did not use condoms. Most reported physical problems with ATS and had above-cut-off scores on PHQ-9 and GAD-7. The majority (95%) reported that they could procure ATS easily. Also, the majority (93%) had thought of quitting ATS use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Most ATS users start using ATS at a young age and have comorbid other drug use, including heroin. ATS use is associated with various physical and psychological problems. Focusing on ATS use in India and developing strategies to address this problem is essential.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/02537176241236899","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T09:22:31Z","timestamp":1712222551000},"page":"223-229","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Patterns and Characteristics of Amphetamine-type Stimulant Use in a North-eastern State of India: A Cross-sectional Study"],"prefix":"10.1177","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1765-1462","authenticated-orcid":false,"given":"Ravindra","family":"Rao","sequence":"first","affiliation":[{"name":"Dept. of Psychiatry, National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8288-2059","authenticated-orcid":false,"given":"Ragul","family":"Ganesh","sequence":"additional","affiliation":[{"name":"All India Institute of Medical Sciences, Vijapur, Jammu and Kashmir, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunal","family":"Kishore","sequence":"additional","affiliation":[{"name":"Alliance India, Zamrudpur, New Delhi, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ira","family":"Madan","sequence":"additional","affiliation":[{"name":"National AIDS Control Organisation, Ministry of Health and Family Welfare, Government of India, New Delhi, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhagwati","family":"Khandpal","sequence":"additional","affiliation":[{"name":"YR Gaitonde Centre for AIDS Research and Education, New Delhi, India."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charanjit","family":"Sharma","sequence":"additional","affiliation":[{"name":"Indian Drug Users Forum, New Delhi, India."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2024,4,4]]},"reference":[{"key":"e_1_3_2_2_2","unstructured":"UNODC. World drug report 2022 www.unodc.org\/unodc\/en\/data-and-analysis\/world-drug-report-2022.html (2022)."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.14688"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1080\/09595230801919460"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/dar.13258"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/14659891.2021.1879289"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2018.08.032"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1080\/10826080701212519"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1300\/J069v17n04_03"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/1057567717730104"},{"key":"e_1_3_2_11_2","volume-title":"Magnitude of substance use in India","author":"Ambekar A","year":"2019","unstructured":"Ambekar A, , Agrawal A, , Rao R, . Magnitude of substance use in India. New Delhi: Ministry of Social Justice and Empowerment, Government of India, 2019."},{"key":"e_1_3_2_12_2","volume-title":"Amphetamine type stimulants (ATS) use in India\u2014an exploratory study","author":"Kumar MS","year":"2015","unstructured":"Kumar MS, and Kumar S. Amphetamine type stimulants (ATS) use in India\u2014an exploratory study. New Delhi: UNODC Regional Office for South Asia, 2015."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7517-11-27"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/dar.12208"},{"key":"e_1_3_2_15_2","unstructured":"United Nations Office on Drugs and Crime. Synthetic drugs in East and South East Asia: latest development and challenges https:\/\/www.unodc.org\/roseap\/uploads\/documents\/Publications\/2022\/Synthetic_Drugs_in_East_and_Southeast_Asia_2022_web.pdf (2022)."},{"key":"e_1_3_2_16_2","volume-title":"The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): manual for use in primary care","author":"Humeniuk R","year":"2010","unstructured":"Humeniuk R. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): manual for use in primary care. Geneva: World Health Organization, 2010."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2001.016009606.x"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.10.1092"},{"key":"e_1_3_2_19_2","volume-title":"2020. ASEAN Drug Monitoring Report 2019","author":"Kanato M","unstructured":"Kanato M, , Choomwattana C, , Rachanikorn S, . (Eds.). 2020. ASEAN Drug Monitoring Report 2019. Bangkok: ASEAN Narcotics Cooperation Center."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lansea.2023.100175"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1139\/jpn.0635"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-011-2383-4"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6912a1"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108162"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.08.029"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2022.2161051"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-023-00816-8"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.03.023"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2019.09.014"},{"key":"e_1_3_2_30_2","first-page":"154","volume-title":"Models of intervention and care for psychostimulant users NDS Monograph","author":"Dawe S","year":"2004","unstructured":"Dawe S, and Ketin M. The psychiatric comorbidity of psychostimulant use. In: Baker A, , Lee NK, , Jenner L. (eds) Models of intervention and care for psychostimulant users NDS Monograph. Canberra: Australian Government Department of Health and Ageing, 2004, pp. 154\u2013168."},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1316.035"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2018.01.020"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1177\/0004867417748750"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2018.02.017"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v67n0211"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1996.9118110.x"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32230-5"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.10.001"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.105020"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.2478\/nsad-2013-0035"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0b013e3182a952b2"},{"key":"e_1_3_2_42_2","unstructured":"United Nations Office on Drugs and Crime. Systematic literature review on HIV and stimulant drugs use\u2014A. Part 2\/5. ATS and HIV risk and transmission https:\/\/www.unodc.org\/documents\/hiv-aids\/2017\/2_Stim_HIV_Syst_Lit_Rev_Part_2_ATS.pdf (2017)."},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0208107"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.olq.0000260949.35304.22"},{"key":"e_1_3_2_45_2","unstructured":"National AIDS Control Organisation. Sankalak: status of national AIDS response. 3rd ed.. http:\/\/naco.gov.in\/sites\/default\/files\/Sankalak_Status_of_National_AIDS_Response_Third_Edition_2021.pdf (2021)."}],"container-title":["Indian Journal of Psychological Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02537176241236899","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02537176241236899","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02537176241236899","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T16:45:07Z","timestamp":1777653907000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02537176241236899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,4]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1177\/02537176241236899"],"URL":"https:\/\/doi.org\/10.1177\/02537176241236899","relation":{},"ISSN":["0253-7176","0975-1564"],"issn-type":[{"value":"0253-7176","type":"print"},{"value":"0975-1564","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,4]]}}}